title: Sequential (domino) transplantation of the liver in a transthyretin-50 familial amyloid polyneuropathy. Special reference to cardiological diagnosis and complications.
abstract: BACKGROUND
  General shortage of cadaveric organs has led to a search for alternative methods to expand the donor pool. Sequential (domino) transplantation is yet another attempt to compensate for the declining consent to organ donation.
  
  
  METHODS
  To qualify for a domino liver transplantation, the following preconditions must be fulfilled: (1) extrahepatic disease must exist, (2) liver must be fully functional, and (3) the genetic defect in the host should recur within a sufficient latency period. Familial amyloid polyneuropathy (FAP) is an autosomal dominant disease which involves a genetic defect for transthyretin (TTR), which is predominantly produced in the liver.
  
  
  RESULTS
  In this report, we describe a rare case of a FAP TTR-50 variant undergoing domino liver transplantation. Since myocardial symptoms precede peripheral polyneuropathy, special emphasis should be placed on arrhythmias and the restrictive cardiomyopathy necessitating a veno-venous bypass or a cardiac pacemaker in order to improve cardiac contractility. The type of anastomosis of the suprahepatic inferior vena cava and possible alternatives are discussed.
  
  
  CONCLUSIONS
  Despite ethical problems, the advantages of the domino procedure are obvious: (1) expansion of the donor pool, (2) ability to use living donors, and (3) presence of very short ischemic time and thus excellent liver function. Due to the kinetics of TTR production and deposition, donors and recipients of FAP livers should be followed up using an extensive neurological and cardiological protocol.
authors.affiliation: Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 110, D-69120 Heidelberg, Germany. Markus_Golling@med.uni-heidelberg.de
authors.forename: M
authors.initials: M
authors.lastname: Golling
authors.forename: R
authors.initials: R
authors.lastname: Singer
authors.forename: G
authors.initials: G
authors.lastname: Weiss
authors.forename: A
authors.initials: A
authors.lastname: Mehrabi
authors.forename: C
authors.initials: C
authors.lastname: Zapletal
authors.forename: T
authors.initials: T
authors.lastname: Kraus
authors.forename: C
authors.initials: C
authors.lastname: Herfarth
authors.forename: E
authors.initials: E
authors.lastname: Klar
mesh_terms: D000328:Adult; D017772:Amyloid Neuropathies / Q000235:genetics / Q000601:surgery*; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D011228:Prealbumin / Q000235:genetics*; D012086:Reoperation; D016896:Treatment Outcome
chemical_list: D011228:Prealbumin